COMPARING COMPLIANCE BY RACE AND ETHNICITY FOR SCHIZOPHRENIA PATIENTS ON ORAL OR LONG-ACTING INJECTABLE ANTIPSYCHOTICS

被引：0
|
作者：
McLean, J. [1 ]
Wei, Y. [2 ]
机构：
[1] Komodo Hlth Inc, Medford, MA USA
[2] Komodo Hlth Inc, San Francisco, CA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCR163
引用
收藏
页码：S326 / S326
页数：1
相关论文
共 50 条
  • [21] Out-of-Pocket Costs for Long-Acting Injectable and Oral Antipsychotics Among Medicare Patients With Schizophrenia
    Doshi, Jalpa A.
    Li, Pengxiang
    Geng, Zhi
    Seo, Sanghyuk
    Patel, Charmi
    Benson, Carmela
    PSYCHIATRIC SERVICES, 2024, 75 (04) : 333 - 341
  • [22] Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder
    Greene, Mallik
    Yan, Tingjian
    Chang, Eunice
    Hartry, Ann
    Touya, Maelys
    Broder, Michael S.
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (02) : 127 - 134
  • [23] CHARACTERISTICS AND HEALTHCARE SERVICE USE OF PATIENTS WITH SCHIZOPHRENIA SWITCHING FROM ORAL TO LONG-ACTING INJECTABLE ANTIPSYCHOTICS
    Wing, V
    Perry, A.
    Brady, B.
    VALUE IN HEALTH, 2019, 22 : S600 - S600
  • [24] The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal
    Brissos, Sofia
    Ruiz-Veguilla, Miguel
    Taylor, David
    Balanza-Martinez, Vicent
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2014, 4 (05) : 198 - 219
  • [25] Long-acting Injectable Antipsychotics in First-episode Schizophrenia
    Jeong, Hyun Ghang
    Lee, Moon Soo
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2013, 11 (01) : 1 - 6
  • [26] Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia
    Parellada, Eduard
    Velligan, Dawn I.
    Emsley, Robin
    Kissling, Werner
    SCHIZOPHRENIA RESEARCH AND TREATMENT, 2012, 2012
  • [27] What Is the Role of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia?
    Stroup, T. Scott
    JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (11) : 1261 - 1262
  • [28] Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan
    Sugawara, Norio
    Kudo, Shuhei
    Ishioka, Masamichi
    Sato, Yasushi
    Kubo, Kazutoshi
    Yasui-Furukori, Norio
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 205 - 211
  • [29] The impact of efficacy of long-acting injectable antipsychotics on caregivers' burden of patients with schizophrenia
    Capuzzi, Enrico
    Quitadamo, Cecilia
    Caldiroli, Alice
    Clerici, Massimo
    Buoli, Massimiliano
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2024, 39 (05) : 333 - 335
  • [30] IMPACT OF INITIATION OF LONG-ACTING INJECTABLE ANTIPSYCHOTICS ON RESOURCE UTILIZATION IN PATIENTS WITH SCHIZOPHRENIA
    Lachaine, J.
    Larbi, M.
    Melnyk, P.
    Rouleau, A.
    Baribeau, V
    Stip, E.
    VALUE IN HEALTH, 2016, 19 (07) : A605 - A605
12345